DoD Clinical and Rehabilitative Medicine Neuromusculoskeletal Injuries Research Award — Defense Health Agency Contracting Activity - DHACA funding opportunity
Defense Health Agency Contracting Activity - DHACA · Federal agency

DoD Clinical and Rehabilitative Medicine Neuromusculoskeletal Injuries Research Award

The FY14 DMRDP CRMRP Neuromusculoskeletal Injuries Research Award (NMSIRA) supports preclinical research and clinical trials on the functional utility of assistive devices related to the human-device interface, secondary...

86
match
Award $0 Deadline 4513 days ago Location Alabama Type grant Level Federal Closed posted Oct 25, 2013
✦ AI Summary
  • Who can apply: Federal-level applicants (see eligibility for details).
  • Funding amount: total funding pool ~$8,300,000.
  • Next deadline: February 11, 2014.
  • Issued by: Defense Health Agency Contracting Activity - DHACA.
How was this generated?

The “key facts” mode pulls structured fields directly from the official source posting (amount, deadline, eligibility tags). The AI mode adds a short plain-English narrative on top, generated from the same source. Always verify with the agency before applying.

AI-generated. Always verify with the official source.

Award amount
$0
Deadline
4513 days ago
Feb 11, 2014
Total pool
$8.3M

About this opportunity

The FY14 DMRDP CRMRP Neuromusculoskeletal Injuries Research Award (NMSIRA) supports preclinical research and clinical trials on the functional utility of assistive devices related to the human-device interface, secondary health effects following severe extremity injury, and optimizing rehabilitation and device prescription for patients with severe extremity trauma.To meet the intent of the award mechanism, applications must specifically address one or more of the FY14 DMRDP CRMRP NMSIRA Focus Areas listed below. Applications proposing research outside of the Focus Areas listed below should not be submitted in response to this Program Announcement/Funding Opportunity.• Improving the functional utility of assistive devices related to the human-device interface (prostheses, orthoses, and other assistive devices)o Improvements in prosthetic socket comfort, residual limb health, and functiono Providing proprioceptive and other sensory inputs to the usero Improving user intent control of assistive devices• Improving the ability to predict, identify and reduce secondary health effects that develop after severe primary neuromusculoskeletal injuryo Determining factors that predict development and successful treatment of osteoarthritis, low back pain, or other musculoskeletal conditionso Intervention strategies to diminish falls and decrease fracture risko Strategies to improve treatment and rehabilitation of heterotopic ossification• Optimizing treatment strategies and sequence of progression throughout the rehabilitation process following severe extremity traumao Determining the optimal timing of rehabilitative techniques to minimize impairments and maximize function and performanceo Objectively guiding prosthetic and/or orthotic prescription to minimize impairments and maximize function and performanceIf the proposed study involves the use of a drug or biologic that has not been approved by the Food and Drug Administration (FDA) for its investigational use, evidence that an Investigational New Drug (IND) exemption application has been submitted or will be submitted within 60 days of award is required. If the proposed study involves an Investigational Device that has not been approved or cleared by FDA for its investigational clinical use, the study may be required to comply with the FDA Investigational Device Exemption (IDE) regulations and evidence that an IDE has been submitted or will be submitted within 60 days of the award date or that the device is exempt from an IDE is required. The Government reserves the right to withdraw funding if the IND or IDE application has not been submitted to the FDA within 60 days of the DoD award date or if the documented status of the IND or IDE has not been obtained within 6 months of the award date.

Funding agency

Tags

Want help applying?

Our specialists will check your eligibility, prepare the application, and walk you through every step — for free. Create a free account →

Who can apply

Eligibility details aren't on file yet — check the agency source link in the Documents tab for the latest rules.

Geographic eligibility

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin
  • Wyoming
  • District of Columbia

How to apply

We don't have application instructions on file yet — head straight to the official source.

Apply on agency site
Tip from our team:

Read the agency's eligibility checklist before you start — it's almost always shorter than the full NOFO and will tell you in 90 seconds whether to keep going.

Need help getting in touch with the right agency contact?

Create a free account and our specialists will guide you through the application end-to-end.

Source documents

View on agency site
Canonical NOFO, application packet, and forms
No supplemental documents yet.

Direct downloads (NOFO PDFs, application forms, FAQs) will appear here once our team attaches them. For now, the agency site has the canonical packet.

Citation details

Source systemgrants.gov
Source ID245473
PostedOct 25, 2013

Frequently asked questions

No FAQs yet.

Have a question about this fund? Sign in to open a ticket about this fund.